NEXPOINT RESIDENTIAL (NXRT) Fundamental Analysis & Valuation

NYSE:NXRT • US65341D1028

Current stock price

28.92 USD
+0.03 (+0.1%)
At close:
28.92 USD
0 (0%)
After Hours:

This NXRT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. NXRT Profitability Analysis

1.1 Basic Checks

  • NXRT had negative earnings in the past year.
  • In the past year NXRT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: NXRT reported negative net income in multiple years.
  • NXRT had a positive operating cash flow in each of the past 5 years.
NXRT Yearly Net Income VS EBIT VS OCF VS FCFNXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M

1.2 Ratios

  • The Return On Assets of NXRT (-1.70%) is worse than 85.00% of its industry peers.
  • NXRT has a worse Return On Equity (-10.84%) than 85.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.20%, NXRT is doing worse than 75.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for NXRT is in line with the industry average of 2.73%.
Industry RankSector Rank
ROA -1.7%
ROE -10.84%
ROIC 1.2%
ROA(3y)0.15%
ROA(5y)0.23%
ROE(3y)-0.54%
ROE(5y)0.3%
ROIC(3y)1.38%
ROIC(5y)1.2%
NXRT Yearly ROA, ROE, ROICNXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • With a Operating Margin value of 11.22%, NXRT is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of NXRT has grown nicely.
  • Looking at the Gross Margin, with a value of 62.91%, NXRT belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
  • NXRT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.22%
PM (TTM) N/A
GM 62.91%
OM growth 3Y-3.14%
OM growth 5Y9.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.61%
GM growth 5Y-7.59%
NXRT Yearly Profit, Operating, Gross MarginsNXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. NXRT Health Analysis

2.1 Basic Checks

  • NXRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • NXRT has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NXRT has been increased compared to 5 years ago.
  • The debt/assets ratio for NXRT is higher compared to a year ago.
NXRT Yearly Shares OutstandingNXRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
NXRT Yearly Total Debt VS Total AssetsNXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 0.37, we must say that NXRT is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.37, NXRT is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
  • NXRT has a Debt/Equity ratio of 5.27. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 5.27, NXRT is doing worse than 90.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.27
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACC0.17
WACC7.11%
NXRT Yearly LT Debt VS Equity VS FCFNXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

2.3 Liquidity

  • NXRT has a Current Ratio of 1.16. This is a normal value and indicates that NXRT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.16, NXRT is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • NXRT has a Quick Ratio of 1.16. This is a normal value and indicates that NXRT is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.16, NXRT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
NXRT Yearly Current Assets VS Current LiabilitesNXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. NXRT Growth Analysis

3.1 Past

  • NXRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.40%, which is quite impressive.
  • NXRT shows a decrease in Revenue. In the last year, the revenue decreased by -3.24%.
  • Measured over the past years, NXRT shows a small growth in Revenue. The Revenue has been growing by 4.18% on average per year.
EPS 1Y (TTM)74.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%351.85%
Revenue 1Y (TTM)-3.24%
Revenue growth 3Y-1.63%
Revenue growth 5Y4.18%
Sales Q2Q%0.54%

3.2 Future

  • The Earnings Per Share is expected to decrease by -1.19% on average over the next years.
  • NXRT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.92% yearly.
EPS Next Y-6.02%
EPS Next 2Y-1.79%
EPS Next 3Y-1.19%
EPS Next 5YN/A
Revenue Next Year1.6%
Revenue Next 2Y2.31%
Revenue Next 3Y1.43%
Revenue Next 5Y1.92%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NXRT Yearly Revenue VS EstimatesNXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M 250M
NXRT Yearly EPS VS EstimatesNXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

0

4. NXRT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NXRT. In the last year negative earnings were reported.
  • Also next year NXRT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXRT Price Earnings VS Forward Price EarningsNXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

  • NXRT's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.4
NXRT Per share dataNXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.79%
EPS Next 3Y-1.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. NXRT Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.34%, NXRT is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 8.94, NXRT pays a better dividend. On top of this NXRT pays more dividend than 90.00% of the companies listed in the same industry.
  • NXRT's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 7.34%

5.2 History

  • On average, the dividend of NXRT grows each year by 10.38%, which is quite nice.
  • NXRT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)10.38%
Div Incr Years0
Div Non Decr Years0
NXRT Yearly Dividends per shareNXRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • NXRT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-167.12%
EPS Next 2Y-1.79%
EPS Next 3Y-1.19%
NXRT Yearly Income VS Free CF VS DividendNXRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M

More info and screens

Find the best dividend stocksShow peers with best dividend

NXRT Fundamentals: All Metrics, Ratios and Statistics

NEXPOINT RESIDENTIAL

NYSE:NXRT (5/1/2026, 8:04:00 PM)

After market: 28.92 0 (0%)

28.92

+0.03 (+0.1%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Industry Strength25.47
Industry Growth35.4
Earnings (Last)04-28
Earnings (Next)07-27
Inst Owners76.66%
Inst Owner Change-1.45%
Ins Owners13.62%
Ins Owner Change4.89%
Market Cap737.17M
Revenue(TTM)251.28M
Net Income(TTM)-32.03M
Analysts73.85
Price Target31.42 (8.64%)
Short Float %4.11%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield 7.34%
Yearly Dividend2.11
Dividend Growth(5Y)10.38%
DP-167.12%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.95%
Min EPS beat(2)-18.22%
Max EPS beat(2)12.33%
EPS beat(4)3
Avg EPS beat(4)5.32%
Min EPS beat(4)-18.22%
Max EPS beat(4)18.46%
EPS beat(8)5
Avg EPS beat(8)57.44%
EPS beat(12)7
Avg EPS beat(12)24.85%
EPS beat(16)8
Avg EPS beat(16)7%
Revenue beat(2)0
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-3.09%
Max Revenue beat(2)-2%
Revenue beat(4)0
Avg Revenue beat(4)-2.09%
Min Revenue beat(4)-3.09%
Max Revenue beat(4)-1.59%
Revenue beat(8)2
Avg Revenue beat(8)3.04%
Revenue beat(12)2
Avg Revenue beat(12)1.35%
Revenue beat(16)4
Avg Revenue beat(16)1.08%
PT rev (1m)-4.35%
PT rev (3m)-8.51%
EPS NQ rev (1m)-12.24%
EPS NQ rev (3m)-11.79%
EPS NY rev (1m)3.51%
EPS NY rev (3m)1.86%
Revenue NQ rev (1m)-0.43%
Revenue NQ rev (3m)-0.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.93
P/FCF N/A
P/OCF 8.82
P/B 2.49
P/tB 2.49
EV/EBITDA 18.4
EPS(TTM)-0.32
EYN/A
EPS(NY)-1.32
Fwd EYN/A
FCF(TTM)-1.27
FCFYN/A
OCF(TTM)3.28
OCFY11.34%
SpS9.86
BVpS11.59
TBVpS11.59
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.7%
ROE -10.84%
ROCE 1.51%
ROIC 1.2%
ROICexc 1.2%
ROICexgc 1.21%
OM 11.22%
PM (TTM) N/A
GM 62.91%
FCFM N/A
ROA(3y)0.15%
ROA(5y)0.23%
ROE(3y)-0.54%
ROE(5y)0.3%
ROIC(3y)1.38%
ROIC(5y)1.2%
ROICexc(3y)1.39%
ROICexc(5y)1.21%
ROICexgc(3y)1.42%
ROICexgc(5y)1.24%
ROCE(3y)1.74%
ROCE(5y)1.52%
ROICexgc growth 3Y-0.7%
ROICexgc growth 5Y12.9%
ROICexc growth 3Y0.67%
ROICexc growth 5Y12.74%
OM growth 3Y-3.14%
OM growth 5Y9.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.61%
GM growth 5Y-7.59%
F-Score3
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 5.27
Debt/FCF N/A
Debt/EBITDA 12.57
Cap/Depr 121.04%
Cap/Sales 46.12%
Interest Coverage 0.34
Cash Conversion 67.44%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 0.37
F-Score3
WACC7.11%
ROIC/WACC0.17
Cap/Depr(3y)78.06%
Cap/Depr(5y)165.13%
Cap/Sales(3y)28.73%
Cap/Sales(5y)63.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%351.85%
EPS Next Y-6.02%
EPS Next 2Y-1.79%
EPS Next 3Y-1.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.24%
Revenue growth 3Y-1.63%
Revenue growth 5Y4.18%
Sales Q2Q%0.54%
Revenue Next Year1.6%
Revenue Next 2Y2.31%
Revenue Next 3Y1.43%
Revenue Next 5Y1.92%
EBIT growth 1Y-8.16%
EBIT growth 3Y-4.72%
EBIT growth 5Y13.61%
EBIT Next Year333.76%
EBIT Next 3Y65.59%
EBIT Next 5YN/A
FCF growth 1Y-188.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.61%
OCF growth 3Y1.86%
OCF growth 5Y7.87%

NEXPOINT RESIDENTIAL / NXRT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NEXPOINT RESIDENTIAL (NXRT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to NXRT.


Can you provide the valuation status for NEXPOINT RESIDENTIAL?

ChartMill assigns a valuation rating of 0 / 10 to NEXPOINT RESIDENTIAL (NXRT). This can be considered as Overvalued.


How profitable is NEXPOINT RESIDENTIAL (NXRT) stock?

NEXPOINT RESIDENTIAL (NXRT) has a profitability rating of 3 / 10.


What is the earnings growth outlook for NEXPOINT RESIDENTIAL?

The Earnings per Share (EPS) of NEXPOINT RESIDENTIAL (NXRT) is expected to decline by -6.02% in the next year.